Hsiangyi Chiang - Aug 29, 2022 Form 3 Insider Report for Imago BioSciences, Inc. (IMGO)

Role: Senior Vice President Finance
Signature: /s/ Hugh Rienhoff, as Attorney-in-fact for Hsiangyi Chiang
Stock symbol: IMGO
Transactions as of: Aug 29, 2022
Transactions value $: $0
Form type: 3
Date filed: 9/2/2022, 05:38 PM
Next filing: Nov 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IMGO	Common Stock						5K	Aug 29, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IMGO	Stock Option (Right to Buy)							Aug 29, 2022	Common Stock	106K	$4.20	Direct	F1
holding	IMGO	Stock Option (Right to Buy)							Aug 29, 2022	Common Stock	23.5K	$22.76	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option (original amount of 119,047) vests with respect to 25% of the shares subject thereto on February 5, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F2	One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 17, 2021 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Content

The option (original amount of 119,047) vests with respect to 25% of the shares subject thereto on February 5, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 17, 2021 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.